Planning Capital Management Corp Ginkgo Bioworks Holdings, Inc. Transaction History
Planning Capital Management Corp
- $142 Billion
- Q2 2024
A detailed history of Planning Capital Management Corp transactions in Ginkgo Bioworks Holdings, Inc. stock. As of the latest transaction made, Planning Capital Management Corp holds 100 shares of DNA stock, worth $801. This represents 0.0% of its overall portfolio holdings.
Number of Shares
100Holding current value
$801% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding DNA
# of Institutions
263Shares Held
912MCall Options Held
1.04MPut Options Held
2.23M-
Viking Global Investors LP143MShares$1.15 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA139MShares$1.11 Billion0.0% of portfolio
-
Baillie Gifford & CO134MShares$1.08 Billion0.04% of portfolio
-
Anchorage Capital Group, L.L.C. New York, NY69.9MShares$560 Million7.28% of portfolio
-
Black Rock Inc. New York, NY42MShares$337 Million0.0% of portfolio
About Ginkgo Bioworks Holdings, Inc.
- Ticker DNA
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 1,287,779,968
- Market Cap $10.3B
- Description
- Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...